Show an ad over header. AMP

I am the FIRST

Vaccine trials fail to capture representative sample of Americans

Note: Trials occurred in the U.S. between 2011 and 2020; Population reflects average U.S. Census figures for 2011 to 2018. Source: 2021 Flores LE et al. JAMA Network Open; Chart: Michelle McGhee/Axios

U.S. vaccine trials over the past decade have not included enough seniors and Hispanic and Black adults, and show a failure to report needed demographic details, according to a study published in JAMA Network Open Friday looking at a large sample of trials.

Why it matters: By not capturing a representative sample of Americans, vaccine trials cannot fully demonstrate the safety and effectiveness for all people and miss out on an opportunity to build trust within underrepresented communities — something vitally important in the COVID-19 pandemic, two experts tell Axios.


  • "It makes it harder to ensure that our drugs and medicines are going to work for all people," says Namandjé Bumpus, director of the department of pharmacology and molecular sciences at Johns Hopkins University School of Medicine.
  • "There are certain genetic variants, particularly involved in drug processing, that seem to very closely track with geography and ancestral origin and can be more prevalent in certain groups than others," says Bumpus, who was not part of the study.
  • Study co-author Steven Pergam says the "downstream effect" of inclusivity is important for building trust in communities for vaccines, particularly "when you look at the data about the clinical trial and you see people like yourself included, and you show the safety and efficacy in those groups."

The state of play: Despite efforts by the NIH and FDA to require more trials to report age, sex, race and ethnicity, most do not comply completely. Examining data from 230 vaccine trials between mid-2011 to mid-2020 with 219,555 participants, the JAMA study found all reported age and sex, but only 58% reported race and 34% ethnicity.

  • "That's a big issue. The reporting is not happening, despite the policies," Bumpus says.
  • While the study paints an incomplete picture partly because of that underreporting, "what we're seeing here is a microcosm for what's going on more broadly with both vaccines and drugs," she says. These are reproducible overall trends in trials, she adds.
  • "We need more outreach and education" to combat the misinformation and long-term distrust that people of color have in the medical community overall and in vaccines specifically, Bumpus says.

Besides the discrepancy in underreporting by most trials, Pergam, associate professor in the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research Center, says an examination of adult trials found:

  • Hispanic (12%) and Black (11%) adults, as well as seniors (12%), were not represented equitably, while white people (78%) and women (56%) tended to be overrepresented.
  • The "definitive" phase three for clinical trials — testing large numbers of the population with the goal of gaining FDA approval — actually had a less-diverse population than the initial trial phases.

Between the lines: Finding less inclusiveness in phase three trials is concerning, and may be due to their focus on "ease and speed" that tends to preclude underrepresented communities who are not as established in the medical system, Pergam says.

  • "The problem is when you aim for speed, you often miss these groups because it does take time and effort ... and you need to prioritize this."
  • COVID-19 trials can serve as a model, Pergam says. "As an example, the Moderna trial did slow down enrollment to make sure they had adequate enrollment of underrepresented minorities, which I think was really key. They put time, they put money, they put people in these groups. They met with community groups ahead of time."

One positive takeaway is that it "debunks this myth that's so prominent right now, that [Black and Hispanic Americans] don't enroll in clinical trials. Clearly we do," Bumpus says. "This [study] shows we're underrepresented but it also shows there clearly is a willingness. We are there. So there are things that can be done to improve that."

The bottom line: Federal agencies and science publications need to get serious about putting some teeth into their policies for studies to report demographics, they said. And trial organizers need to make a concerted effort to reach out to underrepresented communities and set specific diversity enrollment targets.

Check out: Axios' Get Smart videos on vaccines.

Go deeper: The cost of racial disparities in clinical trials

In photos: Brazilians rally against Bolsonaro as COVID deaths top 500,000

Demonstrators took to the streets in at least 22 of Brazil’s 26 states to protest President Jair Bolsonaro's handling of the pandemic — as COVID-19 cases surged past 500,000 on Saturday, per AP.

The big picture: Brazil has the world's second-highest coronavirus death toll and third-highest number of cases. Only 12% of the country's population has been vaccinated against the virus, AP notes.

Keep reading... Show less

Major companies ask Colorado residents not to apply for remote positions

Major companies have said in recent job postings that Colorado residents are ineligible to apply for certain remote positions because a new state law requires businesses to disclose the expected salary or pay range for positions, according to the Wall Street Journal.

Why it matters: The law, which went into effect in January, is meant to help close the gender wage gap and to promote wage transparency for employees, but companies have said Coloradans need not apply to avoid disclosing the information.

Keep reading... Show less

In photos: Communities across nation celebrate Juneteenth

People across the country are celebrating Juneteenth National Independence Day.

The big picture: The date, June 19, memorializes when some of the last enslaved people in Texas learned about their freedom under the Emancipation Proclamation in 1865.

Keep reading... Show less

Separate and unequal paths to business

When a bank turned down George Johnson for a business loan, he got creative. He returned and told the bank he needed $250 to take his wife on a vacation — and was approved. Then he invested the cash in his business, which became the first Black enterprise to trade on the American Stock Exchange.

Why it matters: The highways to success in the U.S. market economy — in entrepreneurship, corporate leadership and wealth creation — are often punctuated with roadblocks and winding detours for people of color.

Keep reading... Show less

Attempting to reform gig work via co-ops

Ride-hailing service The Drivers Cooperative recently debuted in New York City, claiming that its lack of VC funding would result in better driver pay and lower passenger costs.

Why it matters: TDC’s approach is a direct rebuke to the venture capital-fueled gig economy model.

Keep reading... Show less

Conservative cleric Ebrahim Raisi elected Iran's president

Hardliner Ebrahim Raisi easily won Friday's presidential election in Iran, recording 62% of the vote with more than 90% of ballots counted.

Why it matters: Currently the head of Iran's judiciary, Raisi is a close confidant of Supreme Leader Ali Khamenei and has the support of the Islamic Revolutionary Guard Corps (IRGC). His victory solidifies him as a leading candidate to succeed Khamenei, though Friday's low turnout speaks to the disillusionment of many Iranian voters.

Keep reading... Show less

Juneteenth and the country enslaved labor built on the backs of Black Americans

Juneteenth, a once-obscure commemoration of emancipation of enslaved people in Texas, has transformed into an annual reminder about how slavery robbed Black Americans of generational wealth.

Why it matters: That lack of generational wealth still denies Black families the economic security that many white families take for granted.

Keep reading... Show less

Biden will meet with U.S. financial regulators on Monday

President Biden will meet with financial regulators on Monday.

Driving the news: "The meeting will cover regulatory priorities including climate-related financial risk and agency actions to promote financial inclusion and to responsibly increase access to credit," said press secretary Jen Psaki, according to a press pool report.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories